Skip to main content
Caplight Logo









OncoSwab

OncoSwab

Private
CourrouxHealthcare & Life Scienceshttps://oncoswab.com/

Last Round

Grant

May 5, 2025

Total Funding Raised

$4.2M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

OncoSwab is a biotechnology company developing a non-invasive, nasal swab-based diagnostic platform for the early detection of lung cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

lung cancer screeningnasal swabliquid biopsylaboratory developed testLDTgenomic biomarkersnon-invasive diagnosticsearly cancer detectionpulmonary noduleAI diagnosticsprecision medicinectDNAbiotech startupresearch use onlyRUO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OncoSwab Comparables

Compare OncoSwab with similar companies based on industry and business-model similarity.

OncoSwab comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pulmostics
78%
Veracyte
73%
Delfi Diagnostics
70%

OncoSwab Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 5, 2025
Pre SeedOct 25, 2024
Pre SeedMar 12, 2024

Key People

Founding team and executive leadership

Andrea Stephany Diaz

Co-Founder CEO

Founding Team

OncoSwab Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Monthly visitors grew 317% MoM, reaching 1.2K.

  • May 5, 2025

    Secured $1.58M in grant funding.

OncoSwab Filings

Explore SEC and related filing metadata, where available.

OncoSwab filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about OncoSwab's valuation, stock price, and market status.

Is OncoSwab a public or private company?

OncoSwab is a private company.

What is the current stock price of OncoSwab?

OncoSwab is a private company with no public stock price. No recent secondary market data is available.

How much is OncoSwab worth (valuation)?

Valuation information for OncoSwab is not publicly available.

Can I buy OncoSwab stock?

OncoSwab shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was OncoSwab's last funding round?

OncoSwab's most recent funding round was Grant on May 5, 2025.

Who are the main investors in OncoSwab?

Key investors in OncoSwab include Innosuisse.

Will OncoSwab IPO soon?

No public IPO plans have been announced for OncoSwab.

How can I track OncoSwab secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OncoSwab's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCourroux
Employee Range6
Year Founded2023
Last FundingMay 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?